Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 2671 entries
Sorted by: Best Match Show Resources per page
Effects of histamine on intracellular calcium transients recorded with Fura-2 in renal pacemaker cells in guinea pig.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Moss J, Yuan CS, Fatatis A, Attele A.
PMID: 27518021
Inflamm Res. 1997 Mar;46:95-6. doi: 10.1007/s000110050111.

No abstract available.

Cite
Moss J, Yuan CS, Fatatis A, et al. Effects of histamine on intracellular calcium transients recorded with Fura-2 in renal pacemaker cells in guinea pig. Inflamm Res. 1997;46:95-6doi: 10.1007/s000110050111.
Moss, J., Yuan, C. S., Fatatis, A., & Attele, A. (1997). Effects of histamine on intracellular calcium transients recorded with Fura-2 in renal pacemaker cells in guinea pig. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 4695-6. https://doi.org/10.1007/s000110050111
Moss, J, et al. "Effects of histamine on intracellular calcium transients recorded with Fura-2 in renal pacemaker cells in guinea pig." Inflammation research : official journal of the European Histamine Research Society ... [et al.] vol. 46 (1997): 95-6. doi: https://doi.org/10.1007/s000110050111
Moss J, Yuan CS, Fatatis A, Attele A. Effects of histamine on intracellular calcium transients recorded with Fura-2 in renal pacemaker cells in guinea pig. Inflamm Res. 1997 Mar;46:95-6. doi: 10.1007/s000110050111. PMID: 27518021.
Copy Download .nbib Format: NLM
In vitro effect of glucagon-like peptide-1 (7-36)amide, oxyntomodulin, vasoactive intestinal peptide and somatostatin on gastric acid and pepsinogen secretion.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Ben-Hamida A, Houssein AA, Man WK, Spencer J.
PMID: 27518026
Inflamm Res. 1997 Mar;46:105-6. doi: 10.1007/s000110050122.

No abstract available.

Cite
Ben-Hamida A, Houssein AA, Man WK, et al. In vitro effect of glucagon-like peptide-1 (7-36)amide, oxyntomodulin, vasoactive intestinal peptide and somatostatin on gastric acid and pepsinogen secretion. Inflamm Res. 1997;46:105-6doi: 10.1007/s000110050122.
Ben-Hamida, A., Houssein, A. A., Man, W. K., & Spencer, J. (1997). In vitro effect of glucagon-like peptide-1 (7-36)amide, oxyntomodulin, vasoactive intestinal peptide and somatostatin on gastric acid and pepsinogen secretion. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 46105-6. https://doi.org/10.1007/s000110050122
Ben-Hamida, A, et al. "In vitro effect of glucagon-like peptide-1 (7-36)amide, oxyntomodulin, vasoactive intestinal peptide and somatostatin on gastric acid and pepsinogen secretion." Inflammation research : official journal of the European Histamine Research Society ... [et al.] vol. 46 (1997): 105-6. doi: https://doi.org/10.1007/s000110050122
Ben-Hamida A, Houssein AA, Man WK, Spencer J. In vitro effect of glucagon-like peptide-1 (7-36)amide, oxyntomodulin, vasoactive intestinal peptide and somatostatin on gastric acid and pepsinogen secretion. Inflamm Res. 1997 Mar;46:105-6. doi: 10.1007/s000110050122. PMID: 27518026.
Copy Download .nbib Format: NLM
The Incidence of hypotension with continuous infusion atracurium compared to cisatracurium in the Intensive Care Unit.

International journal of critical illness and injury science

VanderWeide LA, Abdel-Rasoul M, Gerlach AT.
PMID: 28660165
Int J Crit Illn Inj Sci. 2017 Apr-Jun;7(2):113-118. doi: 10.4103/IJCIIS.IJCIIS_35_16.

BACKGROUND: A drug shortage of cisatracurium led to use of atracurium as an alternative neuromuscular blocker (NMB). Cisatracurium may be preferred due to less histamine release and potentially less hypotension. The study purpose is to compare the incidence of...

Cite
VanderWeide LA, Abdel-Rasoul M, Gerlach AT. The Incidence of hypotension with continuous infusion atracurium compared to cisatracurium in the Intensive Care Unit. Int J Crit Illn Inj Sci. 2017;7(2):113-118doi: 10.4103/IJCIIS.IJCIIS_35_16.
VanderWeide, L. A., Abdel-Rasoul, M., & Gerlach, A. T. (2017). The Incidence of hypotension with continuous infusion atracurium compared to cisatracurium in the Intensive Care Unit. International journal of critical illness and injury science, 7(2), 113-118. https://doi.org/10.4103/IJCIIS.IJCIIS_35_16
VanderWeide, Luke A, et al. "The Incidence of hypotension with continuous infusion atracurium compared to cisatracurium in the Intensive Care Unit." International journal of critical illness and injury science vol. 7,2 (2017): 113-118. doi: https://doi.org/10.4103/IJCIIS.IJCIIS_35_16
VanderWeide LA, Abdel-Rasoul M, Gerlach AT. The Incidence of hypotension with continuous infusion atracurium compared to cisatracurium in the Intensive Care Unit. Int J Crit Illn Inj Sci. 2017 Apr-Jun;7(2):113-118. doi: 10.4103/IJCIIS.IJCIIS_35_16. PMID: 28660165; PMCID: PMC5479073.
Copy Download .nbib Format: NLM
In Vitro Research Tools in the Field of Human Immediate Drug Hypersensitivity and Their Present Use in Small Animal Veterinary Medicine.

Veterinary sciences

Lavergne SN.
PMID: 29056660
Vet Sci. 2016 Dec 22;4(1). doi: 10.3390/vetsci4010001.

Drug hypersensitivity reactions (DHR) are immune-mediated idiosyncratic adverse drug events. Type I DHR are often referred to as "immediate" and involve B lymphocyte-secreted IgE that bind to the membrane of basophils and mast cells, inducing their degranulation. This review...

Cite
Lavergne SN. In Vitro Research Tools in the Field of Human Immediate Drug Hypersensitivity and Their Present Use in Small Animal Veterinary Medicine. Vet Sci. 2016;4(1)doi: 10.3390/vetsci4010001.
Lavergne, S. N. (2016). In Vitro Research Tools in the Field of Human Immediate Drug Hypersensitivity and Their Present Use in Small Animal Veterinary Medicine. Veterinary sciences, 4(1), . https://doi.org/10.3390/vetsci4010001
Lavergne, Sidonie N.. "In Vitro Research Tools in the Field of Human Immediate Drug Hypersensitivity and Their Present Use in Small Animal Veterinary Medicine." Veterinary sciences vol. 4,1 (2016). doi: https://doi.org/10.3390/vetsci4010001
Lavergne SN. In Vitro Research Tools in the Field of Human Immediate Drug Hypersensitivity and Their Present Use in Small Animal Veterinary Medicine. Vet Sci. 2016 Dec 22;4(1). doi: 10.3390/vetsci4010001. PMID: 29056660; PMCID: PMC5606612.
Copy Download .nbib Format: NLM
Ondansetron and promethazine have differential effects on hypothermic responses to lithium chloride administration and to provocative motion in rats.

Temperature (Austin, Tex.)

Guimaraes DD, Andrews PL, Rudd JA, Braga VA, Nalivaiko E.
PMID: 27227074
Temperature (Austin). 2015 Oct 27;2(4):543-53. doi: 10.1080/23328940.2015.1071700. eCollection 2015.

We recently reported that provocative motion (rotation in a home cage) causes hypothermic responses in rats, similar to the hypothermic responses associated with motion sickness in humans. Many stimuli inducing emesis in species with an emetic reflex also provoke...

Cite
Guimaraes DD, Andrews PL, Rudd JA, et al. Ondansetron and promethazine have differential effects on hypothermic responses to lithium chloride administration and to provocative motion in rats. Temperature (Austin). 2015;2(4):543-53doi: 10.1080/23328940.2015.1071700.
Guimaraes, D. D., Andrews, P. L., Rudd, J. A., Braga, V. A., & Nalivaiko, E. (2015). Ondansetron and promethazine have differential effects on hypothermic responses to lithium chloride administration and to provocative motion in rats. Temperature (Austin, Tex.), 2(4), 543-53. https://doi.org/10.1080/23328940.2015.1071700
Guimaraes, Drielle D, et al. "Ondansetron and promethazine have differential effects on hypothermic responses to lithium chloride administration and to provocative motion in rats." Temperature (Austin, Tex.) vol. 2,4 (2015): 543-53. doi: https://doi.org/10.1080/23328940.2015.1071700
Guimaraes DD, Andrews PL, Rudd JA, Braga VA, Nalivaiko E. Ondansetron and promethazine have differential effects on hypothermic responses to lithium chloride administration and to provocative motion in rats. Temperature (Austin). 2015 Oct 27;2(4):543-53. doi: 10.1080/23328940.2015.1071700. eCollection 2015. PMID: 27227074; PMCID: PMC4843929.
Copy Download .nbib Format: NLM
Author Correction: PKC-dependent phosphorylation of Munc18a at Ser313 in activated RBL-2H3 cells.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Adhikari P, Xu H.
PMID: 29574480
Inflamm Res. 2018 Jun;67(6):553. doi: 10.1007/s00011-018-1143-x.

Acknowledgements This work was supported by the University of Southern Mississippi Development Grant DE01475, the National Institute of Allergy and Infectious Diseases Grant 1R15AI133430-01, and by the Mississippi INBRE, which was funded by an Institutional Development Award (IDeA) from...

Cite
Adhikari P, Xu H. Author Correction: PKC-dependent phosphorylation of Munc18a at Ser313 in activated RBL-2H3 cells. Inflamm Res. 2018;67(6):553doi: 10.1007/s00011-018-1143-x.
Adhikari, P., & Xu, H. (2018). Author Correction: PKC-dependent phosphorylation of Munc18a at Ser313 in activated RBL-2H3 cells. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 67(6), 553. https://doi.org/10.1007/s00011-018-1143-x
Adhikari, Pratikshya, and Xu, Hao. "Author Correction: PKC-dependent phosphorylation of Munc18a at Ser313 in activated RBL-2H3 cells." Inflammation research : official journal of the European Histamine Research Society ... [et al.] vol. 67,6 (2018): 553. doi: https://doi.org/10.1007/s00011-018-1143-x
Adhikari P, Xu H. Author Correction: PKC-dependent phosphorylation of Munc18a at Ser313 in activated RBL-2H3 cells. Inflamm Res. 2018 Jun;67(6):553. doi: 10.1007/s00011-018-1143-x. PMID: 29574480.
Copy Download .nbib Format: NLM
Mast cell mediators: their differential release and the secretory pathways involved.

Frontiers in immunology

Moon TC, Befus AD, Kulka M.
PMID: 25452755
Front Immunol. 2014 Nov 14;5:569. doi: 10.3389/fimmu.2014.00569. eCollection 2014.

Mast cells (MC) are widely distributed throughout the body and are common at mucosal surfaces, a major host-environment interface. MC are functionally and phenotypically heterogeneous depending on the microenvironment in which they mature. Although MC have been classically viewed...

Cite
Moon TC, Befus AD, Kulka M. Mast cell mediators: their differential release and the secretory pathways involved. Front Immunol. 2014;5:569doi: 10.3389/fimmu.2014.00569.
Moon, T. C., Befus, A. D., & Kulka, M. (2014). Mast cell mediators: their differential release and the secretory pathways involved. Frontiers in immunology, 5569. https://doi.org/10.3389/fimmu.2014.00569
Moon, Tae Chul, et al. "Mast cell mediators: their differential release and the secretory pathways involved." Frontiers in immunology vol. 5 (2014): 569. doi: https://doi.org/10.3389/fimmu.2014.00569
Moon TC, Befus AD, Kulka M. Mast cell mediators: their differential release and the secretory pathways involved. Front Immunol. 2014 Nov 14;5:569. doi: 10.3389/fimmu.2014.00569. eCollection 2014. PMID: 25452755; PMCID: PMC4231949.
Copy Download .nbib Format: NLM
Crystal structure of 2-(1H-imidazol-3-ium-4-yl)ethanaminium dichloride, a re-determination.

Acta crystallographica. Section E, Crystallographic communications

Louhibi S, Belfilali I, Boukli-Hacene L, Roisnel T.
PMID: 26594557
Acta Crystallogr E Crystallogr Commun. 2015 Oct 14;71:o844-5. doi: 10.1107/S2056989015018848. eCollection 2015 Nov 01.

The crystal structure of the title mol-ecular salt, C5H11N3 (+)·2Cl(-), was redetermined. In comparison with the previous study [Bonnet et al. (1975 ▸). Bull. Soc. Fr. Mineral. Crist. 98, 208-213.], the positions of some H atoms were corrected, allowing...

Cite
Louhibi S, Belfilali I, Boukli-Hacene L, et al. Crystal structure of 2-(1H-imidazol-3-ium-4-yl)ethanaminium dichloride, a re-determination. Acta Crystallogr E Crystallogr Commun. 2015;71:o844-5doi: 10.1107/S2056989015018848.
Louhibi, S., Belfilali, I., Boukli-Hacene, L., & Roisnel, T. (2015). Crystal structure of 2-(1H-imidazol-3-ium-4-yl)ethanaminium dichloride, a re-determination. Acta crystallographica. Section E, Crystallographic communications, 71o844-5. https://doi.org/10.1107/S2056989015018848
Louhibi, Samira, et al. "Crystal structure of 2-(1H-imidazol-3-ium-4-yl)ethanaminium dichloride, a re-determination." Acta crystallographica. Section E, Crystallographic communications vol. 71 (2015): o844-5. doi: https://doi.org/10.1107/S2056989015018848
Louhibi S, Belfilali I, Boukli-Hacene L, Roisnel T. Crystal structure of 2-(1H-imidazol-3-ium-4-yl)ethanaminium dichloride, a re-determination. Acta Crystallogr E Crystallogr Commun. 2015 Oct 14;71:o844-5. doi: 10.1107/S2056989015018848. eCollection 2015 Nov 01. PMID: 26594557; PMCID: PMC4645084.
Copy Download .nbib Format: NLM
Di-μ-azido-di-azidodi-μ-oxalato-di-histamine-tetra-copper(II) 0.9-hydrate.

Acta crystallographica. Section E, Structure reports online

Liu C, Abboud KA.
PMID: 23794998
Acta Crystallogr Sect E Struct Rep Online. 2013 May 22;69:m337-8. doi: 10.1107/S1600536813013329. Print 2013 Jun 01.

The title compound, [Cu4(C2O4)2(N3)4(C5H9N3)2]·0.9H2O, contains a tetranuclear Cu(II)-based molecule composed of two oxalate-bridged Cu(II) dimers linked through end-on azide ions and related by an inversion center. The tetranuclear unit contains two crystallographically independent Cu(II) ions. One Cu(II) ion coordinates...

Cite
Liu C, Abboud KA. Di-μ-azido-di-azidodi-μ-oxalato-di-histamine-tetra-copper(II) 0.9-hydrate. Acta Crystallogr Sect E Struct Rep Online. 2013;69:m337-8doi: 10.1107/S1600536813013329.
Liu, C., & Abboud, K. A. (2013). Di-μ-azido-di-azidodi-μ-oxalato-di-histamine-tetra-copper(II) 0.9-hydrate. Acta crystallographica. Section E, Structure reports online, 69m337-8. https://doi.org/10.1107/S1600536813013329
Liu, Chen, and Abboud, Khalil A. "Di-μ-azido-di-azidodi-μ-oxalato-di-histamine-tetra-copper(II) 0.9-hydrate." Acta crystallographica. Section E, Structure reports online vol. 69 (2013): m337-8. doi: https://doi.org/10.1107/S1600536813013329
Liu C, Abboud KA. Di-μ-azido-di-azidodi-μ-oxalato-di-histamine-tetra-copper(II) 0.9-hydrate. Acta Crystallogr Sect E Struct Rep Online. 2013 May 22;69:m337-8. doi: 10.1107/S1600536813013329. Print 2013 Jun 01. PMID: 23794998; PMCID: PMC3684896.
Copy Download .nbib Format: NLM
Long distance movement of an Arabidopsis Translationally Controlled Tumor Protein (AtTCTP2) mRNA and protein in tobacco.

Frontiers in plant science

Toscano-Morales R, Xoconostle-Cázares B, Martínez-Navarro AC, Ruiz-Medrano R.
PMID: 25566280
Front Plant Sci. 2014 Dec 17;5:705. doi: 10.3389/fpls.2014.00705. eCollection 2014.

Translationally Controlled Tumor Protein (TCTP) is an almost ubiquitous protein found in eukaryotes, fundamental for the regulation of development and general growth. The multiple functions of TCTP have been inferred from its involvement in several cell pathways, but the...

Cite
Toscano-Morales R, Xoconostle-Cázares B, Martínez-Navarro AC, et al. Long distance movement of an Arabidopsis Translationally Controlled Tumor Protein (AtTCTP2) mRNA and protein in tobacco. Front Plant Sci. 2014;5:705doi: 10.3389/fpls.2014.00705.
Toscano-Morales, R., Xoconostle-Cázares, B., Martínez-Navarro, A. C., & Ruiz-Medrano, R. (2014). Long distance movement of an Arabidopsis Translationally Controlled Tumor Protein (AtTCTP2) mRNA and protein in tobacco. Frontiers in plant science, 5705. https://doi.org/10.3389/fpls.2014.00705
Toscano-Morales, Roberto, et al. "Long distance movement of an Arabidopsis Translationally Controlled Tumor Protein (AtTCTP2) mRNA and protein in tobacco." Frontiers in plant science vol. 5 (2014): 705. doi: https://doi.org/10.3389/fpls.2014.00705
Toscano-Morales R, Xoconostle-Cázares B, Martínez-Navarro AC, Ruiz-Medrano R. Long distance movement of an Arabidopsis Translationally Controlled Tumor Protein (AtTCTP2) mRNA and protein in tobacco. Front Plant Sci. 2014 Dec 17;5:705. doi: 10.3389/fpls.2014.00705. eCollection 2014. PMID: 25566280; PMCID: PMC4269120.
Copy Download .nbib Format: NLM
Histamine and Seizures : Implications for the Treatment of Epilepsy.

CNS drugs

Yokoyama H, Iinuma K.
PMID: 26071045
CNS Drugs. 1996 May;5(5):321-30. doi: 10.2165/00023210-199605050-00002.

Experimental studies have indicated that the central histaminergic neuron system plays an important role in the inhibition of seizures through stimulation of histamine H1 receptors, especially in the developmental period. This has therapeutic implications for currently available drugs that...

Cite
Yokoyama H, Iinuma K. Histamine and Seizures : Implications for the Treatment of Epilepsy. CNS Drugs. 1996;5(5):321-30doi: 10.2165/00023210-199605050-00002.
Yokoyama, H., & Iinuma, K. (1996). Histamine and Seizures : Implications for the Treatment of Epilepsy. CNS drugs, 5(5), 321-30. https://doi.org/10.2165/00023210-199605050-00002
Yokoyama, H, and Iinuma, K. "Histamine and Seizures : Implications for the Treatment of Epilepsy." CNS drugs vol. 5,5 (1996): 321-30. doi: https://doi.org/10.2165/00023210-199605050-00002
Yokoyama H, Iinuma K. Histamine and Seizures : Implications for the Treatment of Epilepsy. CNS Drugs. 1996 May;5(5):321-30. doi: 10.2165/00023210-199605050-00002. PMID: 26071045.
Copy Download .nbib Format: NLM
Prophylactic activity of increasing doses of intravenous histamine in refractory migraine: Retrospective observations of a series of patients with migraine without aura.

Current therapeutic research, clinical and experimental

Pietrini U, De Luca M, Del Bene E, De Cesaris F, Bertinotti L, Colangelo N, Moggi Pignone A.
PMID: 24936105
Curr Ther Res Clin Exp. 2004 Jan;65(1):70-8. doi: 10.1016/S0011-393X(04)90006-9.

BACKGROUND: Histamine is thought to play a pivotal role in the modulation of peripheral and central pain. The administration of increasing doses of histamine may lead to desensitization of receptors of histamine types 1 and 2, causing meningeal vasodilation,...

Cite
Pietrini U, De Luca M, Del Bene E, et al. Prophylactic activity of increasing doses of intravenous histamine in refractory migraine: Retrospective observations of a series of patients with migraine without aura. Curr Ther Res Clin Exp. 2004;65(1):70-8doi: 10.1016/S0011-393X(04)90006-9.
Pietrini, U., De Luca, M., Del Bene, E., De Cesaris, F., Bertinotti, L., Colangelo, N., & Moggi Pignone, A. (2004). Prophylactic activity of increasing doses of intravenous histamine in refractory migraine: Retrospective observations of a series of patients with migraine without aura. Current therapeutic research, clinical and experimental, 65(1), 70-8. https://doi.org/10.1016/S0011-393X(04)90006-9
Pietrini, Umberto, et al. "Prophylactic activity of increasing doses of intravenous histamine in refractory migraine: Retrospective observations of a series of patients with migraine without aura." Current therapeutic research, clinical and experimental vol. 65,1 (2004): 70-8. doi: https://doi.org/10.1016/S0011-393X(04)90006-9
Pietrini U, De Luca M, Del Bene E, De Cesaris F, Bertinotti L, Colangelo N, Moggi Pignone A. Prophylactic activity of increasing doses of intravenous histamine in refractory migraine: Retrospective observations of a series of patients with migraine without aura. Curr Ther Res Clin Exp. 2004 Jan;65(1):70-8. doi: 10.1016/S0011-393X(04)90006-9. PMID: 24936105; PMCID: PMC4052958.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 2671 entries